Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V, Laguillier-Morizot C, Gattegno L, Letourneur D, Charnaux N.

Biochem Pharmacol. 2011 Jan 15;81(2):233-43. doi: 10.1016/j.bcp.2010.09.021. Epub 2010 Sep 29.

PMID:
20887714
2.

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, Charnaux N, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Gattegno L, Pessayre D, Beaugrand M.

Hepatology. 2009 Nov;50(5):1484-93. doi: 10.1002/hep.23187.

PMID:
19731237
3.

Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.

Friand V, Haddad O, Papy-Garcia D, Hlawaty H, Vassy R, Hamma-Kourbali Y, Perret GY, Courty J, Baleux F, Oudar O, Gattegno L, Sutton A, Charnaux N.

Glycobiology. 2009 Dec;19(12):1511-24. doi: 10.1093/glycob/cwp130. Epub 2009 Aug 28.

PMID:
19717493
4.

Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells.

Brule S, Friand V, Sutton A, Baleux F, Gattegno L, Charnaux N.

Biochim Biophys Acta. 2009 Dec;1790(12):1643-50. doi: 10.1016/j.bbagen.2009.08.001. Epub 2009 Aug 17.

PMID:
19695308
5.

Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.

Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff PO, Gattegno L, Oudar O, Sutton A, Charnaux N.

Int J Cancer. 2010 Mar 1;126(5):1095-108. doi: 10.1002/ijc.24800.

6.

Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.

Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A.

Biochim Biophys Acta. 2009 Oct;1790(10):1314-26. doi: 10.1016/j.bbagen.2009.07.015. Epub 2009 Jul 24.

PMID:
19632304
7.

The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells.

Nahon P, Charnaux N, Friand V, Prost-Squarcioni C, Ziol M, Lièvre N, Trinchet JC, Beaugrand M, Gattegno L, Pessayre D, Sutton A.

Free Radic Biol Med. 2008 Nov 1;45(9):1308-17. doi: 10.1016/j.freeradbiomed.2008.08.011. Epub 2008 Aug 15.

PMID:
18760346
8.

Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.

Nahon P, Sutton A, Rufat P, Simon C, Trinchet JC, Gattegno L, Beaugrand M, Charnaux N.

World J Gastroenterol. 2008 Feb 7;14(5):713-9.

9.

Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, Schischmanoff PO, Vidaud D, Charnaux N, Couvert P, Ganne-Carrie N, Trinchet JC, Gattegno L, Beaugrand M.

Gastroenterology. 2008 Jan;134(1):102-10. Epub 2007 Oct 26.

10.

Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.

Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, Vassy R, Haddad O, Sainte-Catherine O, Kraemer M, Saffar L, Perret GY, Courty J, Gattegno L, Charnaux N.

Mol Cancer Ther. 2007 Nov;6(11):2948-58.

11.

Alpha6beta1 integrin expressed by sperm is determinant in mouse fertilization.

Barraud-Lange V, Naud-Barriant N, Saffar L, Gattegno L, Ducot B, Drillet AS, Bomsel M, Wolf JP, Ziyyat A.

BMC Dev Biol. 2007 Sep 12;7:102.

12.

Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.

Nahon P, Sutton A, Rufat P, Faisant C, Simon C, Barget N, Trinchet JC, Beaugrand M, Gattegno L, Charnaux N.

Eur J Gastroenterol Hepatol. 2007 May;19(5):425-31.

PMID:
17413295
13.

Manganese superoxide dismutase dimorphism and iron overload, hepatocellular carcinoma, and death in hepatitis C virus-infected patients.

Nahon P, Sutton A, Pessayre D, Rufat P, Ziol M, Ganne-Carrie N, Charnaux N, Trinchet JC, Gattegno L, Beaugrand M.

Clin Gastroenterol Hepatol. 2007 May;5(5):630-5. Epub 2007 Mar 2.

PMID:
17336594
14.

Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N.

Mol Cancer Res. 2007 Jan;5(1):21-33.

15.

Regulated shedding of syndecan ectodomains by chemokines.

Charnaux N, Sutton A, Brule S, Gattegno L.

ScientificWorldJournal. 2006 Aug 25;6:1037-40. No abstract available.

16.

The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.

Brule S, Charnaux N, Sutton A, Ledoux D, Chaigneau T, Saffar L, Gattegno L.

Glycobiology. 2006 Jun;16(6):488-501. Epub 2006 Mar 2.

PMID:
16513763
17.

Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.

Sutton A, Nahon P, Pessayre D, Rufat P, Poiré A, Ziol M, Vidaud D, Barget N, Ganne-Carrié N, Charnaux N, Trinchet JC, Gattegno L, Beaugrand M.

Cancer Res. 2006 Mar 1;66(5):2844-52.

18.

Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.

Charnaux N, Brule S, Hamon M, Chaigneau T, Saffar L, Prost C, Lievre N, Gattegno L.

FEBS J. 2005 Apr;272(8):1937-51.

19.

Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death.

Nahon P, Sutton A, Pessayre D, Rufat P, Degoul F, Ganne-Carrie N, Ziol M, Charnaux N, N'kontchou G, Trinchet JC, Gattegno L, Beaugrand M.

Clin Gastroenterol Hepatol. 2005 Mar;3(3):292-8.

PMID:
15765450
20.

[Leucocytospermia, oxidative stress and male fertility: facts and hypotheses].

Lemkecher T, Dartigues S, Vaysse J, Kulski O, Barraud-Lange V, Gattegno L, Wolf JP.

Gynecol Obstet Fertil. 2005 Jan-Feb;33(1-2):2-10. Epub 2005 Jan 21. Review. French.

PMID:
15752659
21.

RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.

Charnaux N, Brule S, Chaigneau T, Saffar L, Sutton A, Hamon M, Prost C, Lievre N, Vita C, Gattegno L.

Glycobiology. 2005 Feb;15(2):119-30. Epub 2004 Sep 8.

PMID:
15355933
22.

A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).

Hamon M, Mbemba E, Charnaux N, Slimani H, Brule S, Saffar L, Vassy R, Prost C, Lievre N, Starzec A, Gattegno L.

Glycobiology. 2004 Apr;14(4):311-23. Epub 2004 Mar 19.

PMID:
15033938
23.

Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.

Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L.

Biochim Biophys Acta. 2003 Oct 31;1617(1-2):80-8.

24.

Hypovitaminosis C in hospitalized patients.

Fain O, Pariés J, Jacquart B, Le Moël G, Kettaneh A, Stirnemann J, Héron C, Sitbon M, Taleb C, Letellier E, Bétari B, Gattegno L, Thomas M.

Eur J Intern Med. 2003 Nov;14(7):419-425.

PMID:
14614974
25.

Interactions of heparin with human skin cells: binding, location, and transdermal penetration.

Parisel C, Saffar L, Gattegno L, André V, Abdul-Malak N, Perrier E, Letourneur D.

J Biomed Mater Res A. 2003 Nov 1;67(2):517-23.

PMID:
14566793
26.

Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.

Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L.

Glycobiology. 2003 Sep;13(9):623-34. Epub 2003 May 28.

PMID:
12773479
27.

Human alpha-fetoprotein binds to primary macrophages.

Atemezem A, Mbemba E, Marfaing R, Vaysse J, Pontet M, Saffar L, Charnaux N, Gattegno L.

Biochem Biophys Res Commun. 2002 Aug 23;296(3):507-14.

PMID:
12176010
29.

Glycans are involved in RANTES binding to CCR5 positive as well as to CCR5 negative cells.

Mbemba E, Slimani H, Atemezem A, Saffar L, Gattegno L.

Biochim Biophys Acta. 2001 Feb 9;1510(1-2):354-66.

30.

Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.

Atemezem A, Mbemba E, Vassy R, Slimani H, Saffar L, Gattegno L.

Biochem J. 2001 May 15;356(Pt 1):121-8.

32.

Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.

Albertini JP, Valensi P, Lormeau B, Vaysse J, Attali JR, Gattegno L.

Diabetes Care. 1999 Dec;22(12):2044-8.

33.

Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha.

Mbemba E, Gluckman JC, Gattegno L.

Glycobiology. 2000 Jan;10(1):21-9.

PMID:
10570220
34.

Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.

Thibout D, Kraemer M, Di Benedetto M, Saffar L, Gattegno L, Derbin C, Crépin M.

Anticancer Res. 1999 May-Jun;19(3A):2121-6.

PMID:
10470159
35.

The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state.

Amzazi S, Ylisastigui L, Bakri Y, Rabehi L, Gattegno L, Parmentier M, Gluckman JC, Benjouad A.

Virology. 1998 Dec 5;252(1):96-105.

36.

Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages.

Rabehi L, Seddiki N, Benjouad A, Gluckman JC, Gattegno L.

AIDS Res Hum Retroviruses. 1998 Dec 20;14(18):1605-15. Erratum in: AIDS Res Hum Retroviruses 1999 Mar 20;15(5):493.

PMID:
9870313
37.

Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.

Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferrière F, Attali JR, Gattegno L.

Diabetes Care. 1998 Jun;21(6):1008-13.

PMID:
9614623
38.

Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.

Seddiki N, Rabehi L, Benjouad A, Saffar L, Ferriere F, Gluckman JC, Gattegno L.

Glycobiology. 1997 Dec;7(8):1229-36.

PMID:
9455924
39.

Antiviral activity of derivatized dextrans on HIV-1 infection of primary macrophages and blood lymphocytes.

Seddiki N, Mbemba E, Letourneur D, Ylisastigui L, Benjouad A, Saffar L, Gluckman JC, Jozefonvicz J, Gattegno L.

Biochim Biophys Acta. 1997 Nov 28;1362(1):47-55.

40.

Involvement of the HIV-1 external envelope glycoprotein 120 (gp120) C2 region in gp120 oligomerization.

Seddiki N, Bouhlal H, Rabehi L, Benjouad A, Devaux C, Gluckman JC, Gattegno L.

Biochim Biophys Acta. 1997 Jul 18;1340(2):277-82.

PMID:
9252114
41.

Nuclear and cytoplasmic expressions of the carbohydrate-binding protein CBP70 in tumoral or healthy cells of the macrophagic lineage.

Hadj Sahraoui Y, Sève AP, Doyennette-Moyne MA, Saffar L, Felin M, Aubery M, Gattegno L, Hubert J.

J Cell Biochem. 1996 Sep 15;62(4):529-42.

PMID:
8891898
42.

Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.

Seddiki N, Ben Younes-Chennoufi A, Benjouad A, Saffar L, Baumann N, Gluckman JC, Gattegno L.

AIDS Res Hum Retroviruses. 1996 May 20;12(8):695-703.

PMID:
8744580
43.

Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.

Mbemba E, Carré V, Atemezem A, Saffar L, Gluckman JC, Gattegno L.

AIDS Res Hum Retroviruses. 1996 Jan 1;12(1):47-53.

PMID:
8825618
44.

Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) and of vascular cell adhesion molecule 1 (VCAM-1) in HIV-1 infection.

Gattegno L, Bentata-Peyssare M, Gronowski S, Chaouche K, Ferriere F.

Cell Adhes Commun. 1995 Aug;3(3):179-85.

PMID:
8846020
45.

Interactions of HIV-1 envelope glycoproteins with derivatized dextrans.

Carré V, Mbemba E, Letourneur D, Jozefonvicz J, Gattegno L.

Biochim Biophys Acta. 1995 Feb 23;1243(2):175-80.

PMID:
7532999
46.

alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.

Rabehi L, Ferriere F, Saffar L, Gattegno L.

Glycoconj J. 1995 Feb;12(1):7-16.

PMID:
7795416
47.

The role of calcium and N-linked glycans in the oligomerization and carbohydrate binding properties of human immunodeficiency virus external envelope glycoprotein.

Haidar M, Seddiki N, Gluckman JC, Gattegno L.

Glycoconj J. 1994 Apr;11(2):73-9. Erratum in: Glycoconj J 1994 Oct;11(5):500.

PMID:
7804009
48.

A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus.

Seddiki N, Ramdani A, Saffar L, Portoukalian J, Gluckman JC, Gattegno L.

Biochim Biophys Acta. 1994 Feb 22;1225(3):289-96.

PMID:
8312376
49.
50.

The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein.

Mbemba E, Czyrski JA, Gattegno L.

Biochim Biophys Acta. 1992 Dec 10;1180(2):123-9. Erratum in: Biochim Biophys Acta 1993 Jan 22;1180(3):331.

PMID:
1281430

Supplemental Content

Loading ...
Support Center